Patents
US 8507647 B2: Antibacterial agents for the treatment of gram positive infections
- Granted
- 2013-08-13
- Filed
- 2009-12-18 application 12641465
- Type
- Utility · 15 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
Source: PVGPATDIS, file of 2026-04-10 (ipg130813.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Cubist Pharmaceuticals LLC 29 patents | Foreign company or organization | Lexington, MA | CUBIST PHARMACEUTICALS INC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Chester A. Metcalf, III | Needham, MA | 23 | PVGPATDIS, file of 2026-04-10 | |
| Jing Li | Lansdale, PA | 62 | PVGPATDIS, file of 2026-04-10 | |
| Andre Lee Pearson | Somerville, MA | 2 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07K | Peptides | C07K7/54 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P31/04 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K38/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2022-08-08 | Merger Merger | MERCK SHARP & DOHME CORP. signed 2022-04-07 | MERCK SHARP & DOHME LLC RAHWAY, NJ | 61102/145 | PASDL, file of 2026-10-15 |
| 2015-08-06 | Assignment Nunc pro tunc assignment | CUBIST PHARMACEUTICALS LLC signed 2015-08-05 | MERCK SHARP & DOHME CORP. RAHWAY, NJ | 36268/626 | ECORSEXC, file of 2026-09-25 |
| 2015-08-05 | Name change Change of name | CUBIST PHARMACEUTICALS, INC. signed 2015-06-29 | CUBIST PHARMACEUTICALS LLC KENILWORTH, NJ | 36283/189 | PASDL, file of 2026-10-15 |
| 2015-07-24 | Release of security interest Release of security interest | ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT signed 2015-07-07 | CALIXA THERAPEUTICS, INC. LEXINGTON, MA ADOLOR CORPORATION EXTON, PA CUBIST PHARMACEUTICALS, INC. LEXINGTON, MA | 36180/70 | PASDL, file of 2026-10-15 |
| 2015-07-02 | Assignment Assignment of assignor's interest | CUBIST PHARMACEUTICALS, INC. signed 2015-06-10 | MERCK SHARP & DOHME CORP. RAHWAY, NJ | 35969/613 | ECORSEXC, file of 2026-09-25 |
| 2012-11-20 | Security interest Security interest Security agreement | CUBIST PHARMACEUTICALS, INC. signed 2012-11-20 ADOLOR CORPORATION signed 2012-11-20 CALIXA THERAPEUTICS, INC. signed 2012-11-20 CUBIST PHARMACEUTICALS HOLDINGS, INC. signed 2012-11-20 CUBIST PHARMACEUTICALS U.S. signed 2012-11-20 | ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT TORONTO, ONTARIO | 29339/669 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.